Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Research on Disease Burden of CRE (including non-MBL and MBL-CRE), CR-PA and Stenotrophomonas Maltophilia in ChinaRelease Date:Research Hospital China Research on Diagnostic and Treatment of Invasive Mold DiseaseRelease Date:Research Hospital China Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC)Release Date:Education Oncology Spain Educational approaches to address immunization practice gaps and improve adult vaccination coverage in SwitzerlandRelease Date:Education Vaccines Switzerland Improving Patient Care of Lower Respiratory Tract Infection Among InfantsRelease Date:Quality Improvement Vaccines Thailand China Medical Education in Non-small Cell Lung Cancer Diagnosis, Treatment and Long-Term Disease ManagementRelease Date:Education Oncology China Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology France, Germany, Italy, Japan, Spain, USA, United Kingdom Healthcare Optimization and Patient Equity for Lung Cancer in China (“HOPE”)Release Date:Partner: The International Association for the Study of Lung Cancer (IASLC)Quality Improvement Oncology China Optimizing ER+ Metastatic Breast Cancer Treatment: incorporating emerging treatment options and biomarker testingEducation Oncology All Optimizing vaccination pathways among at-risk or immunocompromised adults and the elderly in ItalyRelease Date:Quality Improvement Vaccines Italy Expanding Access to Maternal Immunization Resources and Point-of-Care ToolsRelease Date:Education Vaccines USA Optimizing ATTR-CM Diagnosis and Care in Heart Failure Patients Quality Improvement Grant Program Request for ProposalsRelease Date:Partner: American College of CardiologyQuality Improvement Rare Disease USA Optimizing maternal immunization practice in Saudi ArabiaRelease Date:Quality Improvement Vaccines Saudi Arabia Role of Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology All Projects of Equalization of Cancer InformationRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for ChildrenRelease Date:Quality Improvement Vaccines Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Improving the Care of Patients with Metastatic Breast Cancer (mBC) Through Innovative StrategiesRelease Date:Partner: The National Comprehensive Cancer Network® (NCCN)Quality Improvement Oncology USA Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older AdultsRelease Date:Quality Improvement Vaccines Japan Clinical Research Capability Development in ChinaRelease Date:Education Support for the Professions China Developing Educational Initiatives for Implementation and Therapy Management of BCMA BsAbs in RRMMRelease Date:Education Oncology USA Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary CareRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology USA The Enhancement of Management of breast cancer in French speaking Sub-Saharan African CountriesRelease Date:Partner: AMFROMQuality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal CancerRelease Date:Education Oncology USA Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)Education Oncology USA Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize ManagementRelease Date:Partner: Beijing Guangda Precision Medicine Research CenterQuality Improvement Inflammation & Immunology China COVID-19 Disease Burden on the Pediatric PopulationRelease Date:Education Vaccines USA Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing ResearchRelease Date:Education Vaccines USA Optimizing Antimicrobial Stewardship Program in Saudi ArabiaRelease Date:Quality Improvement Inflammation & Immunology Saudi Arabia Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology All Pharmacokinetics-pharmacodynamics (PK-PD) of aztreonam-avibactam (ATM-AVI) in Special PopulationsRelease Date:Research Inflammation & Immunology Austria, Denmark, Finland, Germany, Italy, Netherlands, Norway, Romania, Spain, Sweden, United Kingdom Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with IsavuconazoleRelease Date:Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland Optimizing maternal immunization practice in Malaysia Indonesia Singapore PhilippinesRelease Date:Quality Improvement Vaccines Indonesia, Malaysia, Philippines, Singapore PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate CancerRelease Date:Education Oncology USA Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026Release Date:Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infectionRelease Date:Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac eraRelease Date:Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRERelease Date:Research Hospital China, Hong Kong COVID-19 Disease Burden on the High Risk PopulationRelease Date:Education Vaccines All New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel DiseaseRelease Date:Research Inflammation & Immunology USA Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)Release Date:Education Oncology USA Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)Education Oncology USA Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with ComorbiditiesRelease Date:Education Inflammation & Immunology USA Antimicrobial Stewardship in the Sub-Saharan African RegionRelease Date:Partner: International Society for Infectious DiseasesQuality Improvement Inflammation & Immunology All Enhancing Patient-Centered Outcomes in Emergency Department Migraine ManagementRelease Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA